The effect of glycosylation on plasma N-terminal proBNP-76 levels in patients with heart or renal failure

Heart

Volumn 98, Issue 2, 2012, Pages 152-161

  Nishikimi, Toshio ^a,b   Ikeda, Masashi ^b   Takeda, Yosuke ^b   Ishimitsu, Toshihiko ^b   Shibasaki, Ikuko ^b   Fukuda, Hirotsugu ^b   Kinoshita, Hideyuki ^a   Nakagawa, Yasuaki ^a   Kuwahara, Koichiro ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CYCLIC GMP; GLYCOSYLATED PROTEIN; NATRIURETIC FACTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION;

AGED; AGED, 80 AND OVER; FEMALE; GLYCOSYLATION; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS;

EID: 84155167865     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300102     Document Type: Article

References (30)

1. Nishikimi T, Kuwahara K, Nakao K. Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides. J Cardiol 2011;57:131-40.
2. Nishikimi T, Maeda N, Matsuoka H. The role of natriuretic peptides in cardioprotection. Cardiovasc Res 2006;69:318-28. (Pubitemid 43098788)
3. Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 2006;92:843-9. (Pubitemid 43799232)
4. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007;50:2357-68. (Pubitemid 50011582)
5. Schellenberger U, O'Rear J, Guzzetta A, et al. The precursor to B-type natriuretic peptide is an O-linked glycoprotein. Arch Biochem Biophys 2006;451:160-6.
6. Liang F, O'Rear J, Schellenberger U, et al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J Am Coll Cardiol 2007;49:1071-8. (Pubitemid 46349497)
7. Seferian KR, Tamm NN, Semenov AG, et al. Immunodetection of glycosylated NT-proBNP circulating in human blood. Clin Chem 2008;54:866-73. (Pubitemid 351671597)
8. Luckenbill KN, Christenson RH, Jaffe AS, et al. Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. Clin Chem 2008;54:619-21. (Pubitemid 351348175)
9. Hammerer-Lercher A, Halfinger B, Sarg B, et al. Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure. Clin Chem 2008;54:858-65. (Pubitemid 351671596)
10. Nishikimi T, Minamino N, Ikeda M, et al. Diversity of molecular forms of plasma brain natriuretic peptide in heart failure - different proBNP-108 to BNP-32 ratios in atrial and ventricular overload. Heart 2010;96:432-9.
11. Nishikimi T, Saito Y, Kitamura K, et al. Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol 1995;26:1424-31.
12. Nishikimi T, Karasawa T, Inaba C, et al. Effects of long-term intravenous administration of adrenomedullin (AM) plus hANP therapy in acute decompensated heart failure: a pilot study. Circ J 2009;73:892-8.
13. Yoshitomi Y, Nishikimi T, Abe H, et al. Comparison of changes in cardiac structure after treatment in secondary hypertension. Hypertension 1996;27:319-23. (Pubitemid 26082073)
14. Quiones GA, Douglas PS, Foster E, et al. ACC/AHA clinical competence statement on echocardiography: a report of the American College of Cardiology/ American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence. Developed in collaboration with the American Society of Echocardiography, the Society of Cardiovascular Anesthesiologists, and the Society of Pediatric Echocardiography. J Am Coll Cardiol 2003;41:687-708. (Pubitemid 36230921)
15. Waldo SW, Beede J, Isakson S, et al. Pro-B-type natriuretic peptide levels in acute decompensated heart failure. J Am Coll Cardiol 2008;51:1874-82. (Pubitemid 351615249)
16. Xu-Cai YO, Wu Q. Molecular forms of natriuretic peptides in heart failure and their implications. Heart 2010;96:419-24.
17. Vickery S, Price CP, John RI, et al. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis 2005;46:610-20. (Pubitemid 41383938)
18. Sakai H, Tsutamoto T, Ishikawa C, et al. Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP secretion and extent of coronary artery stenosis in patients with stable coronary artery disease. Circ J 2007;71:499-505. (Pubitemid 46513455)
19. Spanaus KS, Kronenberg F, Ritz E, et al. Mild-to-Moderate Kidney Disease Study Group. B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study. Clin Chem 2007;53:1264-72. (Pubitemid 47020982)
20. Eklund EA, Freeze HH. Essentials of glycosylation. Semin Pediatr Neurol 2005;12:134-43. (Pubitemid 43340144)
21. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993;3:97-130. (Pubitemid 23132602)
22. Zachara NE, Hart GW. The emerging significance of O-GlcNAc in cellular regulation. Chem Rev 2002;102:431-8. (Pubitemid 35377621)
23. Jiang J, Pristera N, Wang W, et al. Effect of sialylated O-glycans in pro-brain natriuretic peptide stability. Clin Chem 2010;56:959-66.
24. deFilippi CR, Seliger SL, Maynard S, et al. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. Clin Chem 2007;53:1511-19. (Pubitemid 47206349)
25. Schou M, Alehagen U, Goetze JP, et al. Effect of estimated glomerular filtration rate on plasma concentrations of B-type natriuretic peptides measured with multiple immunoassays in elderly individuals. Heart 2009;95:1514-19.
26. Bargnoux AS, Klouche K, Fareh J, et al. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration. Clin Chem Lab Med 2008;46:1019-24. (Pubitemid 352000496)
27. Racek J, Krlov H, Trefil L, et al. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients. Nephron Clin Pract 2006;103:162-72.
28. Wahl HG, Graf S, Renz H, et al. Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis. Clin Chem 2004;50:1071-4. (Pubitemid 38725801)
29. Nishikimi T, Futoo Y, Tamano K, et al. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease. Am J Kidney Dis 2001;37:1201-8. (Pubitemid 32525156)
30. Frankenstein L, Clark AL, Goode K, et al. The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age. Heart 2009;95:825-9.